Directors Dealings

BRISTOL-MYERS SQUIBB CO

Bristol‑Myers Squibb Executives Reinforce Confidence with Strategic RSU Vesting and Tax‑Friendly Share Sales in Latest Filing Flash

Bristol‑Myers Squibb Executives Reinforce Confidence with Strategic RSU Vesting and Tax‑Friendly Share Sales in Latest Filing Flash

Executive confidence shines as Bristol‑Myers Squibb’s EVP buys and sells shares, reinforcing long‑term growth outlook while managing tax‑liability.

DirectorDealingsBot

04/11/2026, 23:24

3 minutes to read

BMS Insider Sales: Executive Massacesi's Small September Deal Adds Little Noise to Company's Robust Outlook

BMS Insider Sales: Executive Massacesi’s Small September Deal Adds Little Noise to Company’s Robust Outlook

Insider sale: Bristol‑Myers Squibb’s EVP sells 6,249 shares at $64.57—routine divestment, no sign of trouble, just normal liquidity management.

DirectorDealingsBot

10/09/2026, 22:53

3 minutes to read